Blog

How Can We Exercise Our Mind?: Mindshifting Moments #7

Aug 23 • 1 min read

The Brain is a Muscle, Right? We often hear about how psychedelics create new pathways in the brain. This is most commonly referred to as the brain’s neuroplasticity. But how does it all work? What is the science behind all of it? The Intuition Method In this edition of Mindshifting Moments, host Margaret Williamson welcomes…

Field Trip Health & Wellness Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 30, 2022, at 8:30 A.M. ET

Aug 23 • 2 min read

Field Trip Health & Wellness Ltd. (TSXV: FTHW), a global leader in psychedelic therapies, announced today that it plans to release financial results for its fiscal 2023 first quarter for the three-month period ended June 30, 2022, after market close on Monday, August 29, 2022. The Company will conduct a conference call and webcast to discuss its results…

Another Public Company First: Silo Wellness Opens Jamaican Ecotourism Psilocybin Microdosing Resort for the Psychedelic Curious; Shareholder Discounts for Psychedelic Vacations Available

Aug 23 • 9 min read

Silo Wellness Inc. (CSE: SILO | OTCQB: SILFF | FSE: 3K7A), a leading global psychedelics company, is pleased to announce that it has opened its first ecotourism microdosing psilocybin resort and retreat center at Go Natural Jamaica in Long Bay, Portland, Jamaica. “We have been bombarded by cost-conscious client inquiries wanting to explore nature with the help…

Cybin Corporate Presentation – August 2022

Aug 23 • 12 min read

August 2022 Cautionary Statement The information contained in this presentation has been prepared by Cybin Inc. and its affiliates (“Cybin” or the “Company”). The information contained in this presentation: (a) is provided as at the date hereof, is subject to change without notice, and is based on publicly available information, internally developed data and third-party…

Small Pharma Announces TSXV Approval of Normal Course Issuer Bid

Aug 23 • 3 min read

Small Pharma Inc. (TSXV: DMT | OTCQB: DMTTF), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that the TSX Venture Exchange (the “TSXV”) has accepted the Company’s application for its normal course issuer bid (the “NCIB”) for up to five million common shares (“Shares”) in the capital of the…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538